10x Genomics (TXG) Capital Expenditures Growth (3y) (2021 - 2026)

10x Genomics (TXG) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -16.04%
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 11.49%
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 411.55%
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 60.17%
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 15.83%
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Privia Health 2.78 Bn 2.42 Bn - -198.88%

Historic Data

Download Data
DateValue
Jun 30, 2026 60.17%
Mar 31, 2026 -70.42%
Dec 31, 2025 -47.35%
Sep 30, 2025 -26.09%
Jun 30, 2025 -27.21%
Mar 31, 2025 -59.33%
Dec 31, 2024 -32.03%
Sep 30, 2024 -61.11%
Jun 30, 2024 28.55%
Mar 31, 2024 -63.44%
Dec 31, 2023 26.67%
Sep 30, 2023 -36.57%
Jun 30, 2023 148.40%
Mar 31, 2023 17.49%
Dec 31, 2022 178.84%
Sep 30, 2022 62.44%
Jun 30, 2022 12.19%
Mar 31, 2022 105.76%
Dec 31, 2021 167.07%